Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Predict S.P.A. Class B ( (IT:PRE) ) just unveiled an update.
Predict S.p.A. has called an Ordinary Shareholders’ Meeting for 23 April 2026, with a possible second call on 28 April, to be held exclusively via telecommunication with participation only through an appointed representative. The agenda includes approval of the 2025 financial statements, allocation of profits, and renewal of authorization to purchase and dispose of treasury shares, underscoring governance continuity and potential balance sheet flexibility for the med-tech group.
The company detailed its current share capital structure of 7,771,000 shares, including ordinary, multiple voting, and special price adjustment shares, and disclosed it holds 48,000 treasury shares. It also set record and communication dates for intermediaries to certify voting rights, clarifying procedures for remote participation and representation to ensure orderly shareholder engagement despite restrictions on physical attendance.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A. is an innovative Italian SME operating in the med-tech sector, focused on in vivo diagnostics. The company distributes ultrasound and radiological equipment and develops technologies for breath analysis and digital healthcare, targeting advanced diagnostic solutions for healthcare providers.
Average Trading Volume: 26,400
Technical Sentiment Signal: Sell
Current Market Cap: €5.79M
Find detailed analytics on PRE stock on TipRanks’ Stock Analysis page.